has activity against a broad range of pathogens associated with community-acquired bacterial pneumonia, including: Streptococcus pneumoniae, Streptococcus pyogenes, and erythromycin-resistant Staphylococcus aureus
Source
Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e01096-17.
